First Merchants Corp Eli Lilly & CO Transaction History

First Merchants Corp

$1.42 Billion
Q3 2024

A detailed history of First Merchants Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, First Merchants Corp holds 56,031 shares of LLY stock, worth $40.9 Million. This represents 3.49% of its overall portfolio holdings.

Number of Shares

56,031

Previous 56,119 0.16%

Holding current value

$40.9 Million

Previous $50.8 Million 2.3%

% of portfolio

3.49%

Previous 3.72%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$772.14 - $960.02 $67,948 - $84,481	-88 Reduced 0.16%	56,031 $49.6 Million
Q2 2024 Jul 25, 2024	BUY	$724.87 - $909.04 $3.26 Million - $4.08 Million	4,492 Added 8.7%	56,119 $50.8 Million
Q1 2024 Apr 25, 2024	BUY	$592.2 - $792.28 $489,749 - $655,215	827 Added 1.63%	51,627 $40.2 Million
Q4 2023 Jan 25, 2024	BUY	$525.19 - $619.13 $388,640 - $458,156	740 Added 1.48%	50,800 $29.6 Million
Q3 2023 Oct 26, 2023	BUY	$434.7 - $599.3 $148,667 - $204,960	342 Added 0.69%	50,060 $26.9 Million
Q2 2023 Jul 25, 2023	BUY	$350.74 - $468.98 $102,766 - $137,411	293 Added 0.59%	49,718 $23.3 Million
Q1 2023 Apr 25, 2023	SELL	$310.63 - $364.82 $205,015 - $240,781	-660 Reduced 1.32%	49,425 $17 Million
Q4 2022 Jan 26, 2023	SELL	$321.55 - $374.67 $3.83 Million - $4.46 Million	-11,899 Reduced 19.2%	50,085 $0
Q3 2022 Oct 25, 2022	SELL	$296.48 - $337.87 $122,742 - $139,878	-414 Reduced 0.66%	61,984 $20 Million
Q2 2022 Jul 26, 2022	SELL	$278.73 - $327.27 $203,751 - $239,234	-731 Reduced 1.16%	62,398 $20.2 Million
Q1 2022 Apr 26, 2022	SELL	$234.69 - $291.66 $31,683 - $39,374	-135 Reduced 0.21%	63,129 $18.1 Million
Q4 2021 Jan 27, 2022	SELL	$224.85 - $279.04 $3.66 Million - $4.54 Million	-16,285 Reduced 20.47%	63,264 $17.5 Million
Q3 2021 Oct 26, 2021	SELL	$221.6 - $272.71 $131,852 - $162,262	-595 Reduced 0.74%	79,549 $18.4 Million
Q2 2021 Jul 26, 2021	SELL	$180.55 - $233.54 $1.49 Million - $1.93 Million	-8,243 Reduced 9.33%	80,144 $18.4 Million
Q1 2021 Apr 22, 2021	BUY	$164.32 - $212.72 $1.01 Million - $1.31 Million	6,137 Added 7.46%	88,387 $16.5 Million
Q4 2020 Jan 28, 2021	BUY	$130.46 - $172.63 $522,883 - $691,901	4,008 Added 5.12%	82,250 $13.9 Million
Q3 2020 Oct 28, 2020	BUY	$146.22 - $169.13 $3.89 Million - $4.5 Million	26,611 Added 51.54%	78,242 $11.6 Million
Q2 2020 Jul 23, 2020	SELL	$136.42 - $164.18 $81,033 - $97,522	-594 Reduced 1.14%	51,631 $8.48 Million
Q1 2020 Apr 23, 2020	BUY	$119.05 - $147.35 $33,095 - $40,963	278 Added 0.54%	52,225 $7.24 Million
Q4 2019 Jan 30, 2020	SELL	$106.92 - $132.43 $78,800 - $97,600	-737 Reduced 1.4%	51,947 $6.83 Million
Q3 2019 Oct 24, 2019	BUY	$106.79 - $116.16 $180,795 - $196,658	1,693 Added 3.32%	52,684 $5.89 Million
Q2 2019 Jul 25, 2019	BUY	$110.79 - $129.32 $176,377 - $205,877	1,592 Added 3.22%	50,991 $5.65 Million
Q1 2019 Apr 25, 2019	SELL	$111.31 - $131.02 $48,753 - $57,386	-438 Reduced 0.88%	49,399 $6.41 Million
Q4 2018 Jan 31, 2019	BUY	$105.9 - $118.64 $21,180 - $23,728	200 Added 0.4%	49,837 $5.77 Million
Q3 2018 Oct 24, 2018	BUY	$85.86 - $107.31 $199,023 - $248,744	2,318 Added 4.9%	49,637 $5.33 Million
Q2 2018 Jul 26, 2018	BUY	$75.7 - $86.88 $69,719 - $80,016	921 Added 1.98%	47,319 $4.04 Million
Q1 2018 Apr 26, 2018	BUY	$74.21 - $87.6 $1.21 Million - $1.43 Million	16,331 Added 54.32%	46,398 $3.59 Million
Q4 2017 Jan 30, 2018	BUY	$81.94 - $87.89 $3,031 - $3,251	37 Added 0.12%	30,067 $2.54 Million
Q3 2017 Oct 31, 2017	BUY	$77.07 - $85.54 $2.31 Million - $2.57 Million	30,030	30,030 $2.57 Million

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $693B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Merchants Corp, based on Form 13F filings with the SEC.

News

Stay updated on First Merchants Corp with notifications on news.

Account

First Merchants Corp Eli Lilly & CO Transaction History